UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 109

Sortiert nach

Harms in Systematic Reviews Paper 1: An introduction to research on harms

Journal of clinical epidemiology, 2022-03, Vol.143, p.186-196

2022

Link zum Volltext

Verfügbarkeit prüfen

Should E-Cigarette Regulation Be Based on Randomized Trials or Observational Studies?

American journal of public health (1971), 2021-02, Vol.111 (2), p.219-220

Mayo-Wilson, Evan

2021

Link zum Volltext

Verfügbarkeit prüfen

Harms were detected but not reported in six clinical trials of gabapentin

Journal of clinical epidemiology, 2023-12, Vol.164, p.76-87

2023

Link zum Volltext

Verfügbarkeit prüfen

Open Science Standards at Journals that Inform Evidence-Based Policy

Prevention science, 2023-10, Vol.24 (7), p.1275-1291

2023

Link zum Volltext

Verfügbarkeit prüfen

Clearinghouse Standards of Evidence on the Transparency, Openness, and Reproducibility of Intervention Evaluations

Prevention science, 2022-07, Vol.23 (5), p.774-786

2022

Link zum Volltext

Verfügbarkeit prüfen

Modern Meta-Analytic Methods in Prevention Science: Introduction to the Special Issue

Prevention science, 2022-04, Vol.23 (3), p.341-345

2022

Link zum Volltext

Verfügbarkeit prüfen

The Oxford Implementation Index: a new tool for incorporating implementation data into systematic reviews and meta-analyses

Journal of clinical epidemiology, 2013-08, Vol.66 (8), p.874-882

2013

Link zum Volltext

Verfügbarkeit prüfen

Cherry-picking by trialists and meta-analysts can drive conclusions about intervention efficacy

Journal of clinical epidemiology, 2017-11, Vol.91, p.95-110

2017

Link zum Volltext

Verfügbarkeit prüfen

Multiple outcomes and analyses in clinical trials create challenges for interpretation and research synthesis

Journal of clinical epidemiology, 2017-06, Vol.86, p.39-50

2017

Link zum Volltext

Verfügbarkeit prüfen

Reporting Implementation in Randomized Trials: Proposed Additions to the Consolidated Standards of Reporting Trials Statement

American journal of public health (1971), 2007-04, Vol.97 (4), p.630-633

Mayo-Wilson, Evan

2007

Link zum Volltext

Verfügbarkeit prüfen

Harms in Systematic Reviews Paper 2: Methods used to assess harms are neglected in systematic reviews of gabapentin

Journal of clinical epidemiology, 2022-03, Vol.143, p.212-223

2022

Link zum Volltext

Verfügbarkeit prüfen

Methodology reporting improved over time in 176,469 randomized controlled trials

Journal of clinical epidemiology, 2023-10, Vol.162, p.19-28

2023

Link zum Volltext

Verfügbarkeit prüfen

The selection of comparators for randomized controlled trials of health-related behavioral interventions: recommendations of an NIH expert panel

Journal of clinical epidemiology, 2019-06, Vol.110, p.74-81

2019

Link zum Volltext

Verfügbarkeit prüfen

Transparent, Open, and Reproducible Prevention Science

Prevention science, 2022-07, Vol.23 (5), p.701-722

2022

Link zum Volltext

Verfügbarkeit prüfen

Harms are assessed inconsistently and reported inadequately Part 2: nonsystematic adverse events

Journal of clinical epidemiology, 2019-09, Vol.113, p.11-19

2019

Link zum Volltext

Verfügbarkeit prüfen

Comparing the Value of Data Visualization Methods for Communicating Harms in Clinical Trials

Epidemiologic reviews, 2022-12, Vol.44 (1), p.55-66

2022

Link zum Volltext

Verfügbarkeit prüfen

Harms are assessed inconsistently and reported inadequately part 1: systematic adverse events

Journal of clinical epidemiology, 2019-09, Vol.113, p.20-27

2019

Link zum Volltext

Verfügbarkeit prüfen

CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomized trials

Journal of clinical epidemiology, 2023-06, Vol.158, p.149-165

2023

Link zum Volltext

Verfügbarkeit prüfen

Scientific Reporting: Raising the Standards

Health education & behavior, 2016-10, Vol.43 (5), p.501-508

2016

Link zum Volltext

Verfügbarkeit prüfen

Developing a reporting guideline for social and psychological intervention trials

American journal of public health (1971), 2013-10, Vol.103 (10), p.1741-1746

2013

Link zum Volltext

Verfügbarkeit prüfen

Evidence Clearinghouses as Tools to Advance Health Equity: What We Know from a Systematic Scan

Prevention science, 2023-05, Vol.24 (4), p.613-624

2023

Link zum Volltext

Verfügbarkeit prüfen

Rapid network meta-analysis using data from Food and Drug Administration approval packages is feasible but with limitations

Journal of clinical epidemiology, 2019-10, Vol.114, p.84-94

2019

Link zum Volltext

Verfügbarkeit prüfen

Improving the analysis of adverse event data in randomized controlled trials

Journal of clinical epidemiology, 2022-04, Vol.144, p.185-192

2022

Link zum Volltext

Verfügbarkeit prüfen

Strengthening causal inference from randomised controlled trials of complex interventions

BMJ global health, 2022-06, Vol.7 (6), p.e008597

2022

Link zum Volltext

Verfügbarkeit prüfen

Nitrate and nitrite contamination in drinking water and cancer risk: A systematic review with meta-analysis

Environmental research, 2022-07, Vol.210, p.112988, Article 112988

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 109

Suche als RSS-Feed

Aktive Filter

SpracheSpanisch

ThemaPublic, Environmental & Occupational Health

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(101)
Mit Volltextzugriff
(106)

Publikationsform

Artikel
(109)

Sprache

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Harms in Systematic Reviews Paper 1: An introduction to research on harms

Should E-Cigarette Regulation Be Based on Randomized Trials or Observational Studies?

Harms were detected but not reported in six clinical trials of gabapentin

Open Science Standards at Journals that Inform Evidence-Based Policy

Clearinghouse Standards of Evidence on the Transparency, Openness, and Reproducibility of Intervention Evaluations

Modern Meta-Analytic Methods in Prevention Science: Introduction to the Special Issue

The Oxford Implementation Index: a new tool for incorporating implementation data into systematic reviews and meta-analyses

Cherry-picking by trialists and meta-analysts can drive conclusions about intervention efficacy

Multiple outcomes and analyses in clinical trials create challenges for interpretation and research synthesis

Reporting Implementation in Randomized Trials: Proposed Additions to the Consolidated Standards of Reporting Trials Statement

Harms in Systematic Reviews Paper 2: Methods used to assess harms are neglected in systematic reviews of gabapentin

Methodology reporting improved over time in 176,469 randomized controlled trials

The selection of comparators for randomized controlled trials of health-related behavioral interventions: recommendations of an NIH expert panel

Transparent, Open, and Reproducible Prevention Science

Harms are assessed inconsistently and reported inadequately Part 2: nonsystematic adverse events

Comparing the Value of Data Visualization Methods for Communicating Harms in Clinical Trials

Harms are assessed inconsistently and reported inadequately part 1: systematic adverse events

CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomized trials

Scientific Reporting: Raising the Standards

Developing a reporting guideline for social and psychological intervention trials

Evidence Clearinghouses as Tools to Advance Health Equity: What We Know from a Systematic Scan

Rapid network meta-analysis using data from Food and Drug Administration approval packages is feasible but with limitations

Improving the analysis of adverse event data in randomized controlled trials

Strengthening causal inference from randomised controlled trials of complex interventions

Nitrate and nitrite contamination in drinking water and cancer risk: A systematic review with meta-analysis

Aktive Filter

Suchergebnisse filtern